These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection. Miller DS, Halpern M, Kotlarski I, Jilbert AR. Virology; 2006 May 10; 348(2):297-308. PubMed ID: 16469347 [Abstract] [Full Text] [Related]
4. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner. Miller DS, Kotlarski I, Jilbert AR. Virology; 2006 Jul 20; 351(1):159-69. PubMed ID: 16624364 [Abstract] [Full Text] [Related]
5. Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection. Foster WK, Miller DS, Scougall CA, Kotlarski I, Colonno RJ, Jilbert AR. J Virol; 2005 May 20; 79(9):5819-32. PubMed ID: 15827196 [Abstract] [Full Text] [Related]
6. Antiviral effects of PNA in duck hepatitis B virus infection model. Chen ZY, Cheng AC, Wang MS, Xu DW, Zeng W, Li Z. Acta Pharmacol Sin; 2007 Oct 20; 28(10):1652-8. PubMed ID: 17883953 [Abstract] [Full Text] [Related]
7. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis. Reaiche GY, Le Mire MF, Mason WS, Jilbert AR. Virology; 2010 Oct 25; 406(2):286-92. PubMed ID: 20705309 [Abstract] [Full Text] [Related]
8. Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection. Foster WK, Miller DS, Marion PL, Colonno RJ, Kotlarski I, Jilbert AR. Antimicrob Agents Chemother; 2003 Aug 25; 47(8):2624-35. PubMed ID: 12878529 [Abstract] [Full Text] [Related]
9. Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks. Jilbert AR, Miller DS, Scougall CA, Turnbull H, Burrell CJ. Virology; 1996 Dec 15; 226(2):338-45. PubMed ID: 8955053 [Abstract] [Full Text] [Related]
10. [Inhibitory effect of trisodium phosphonoformate (PFA) on duck hepatitis B virus (DHBV) DNA in vivo]. Chen X, Chen H. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep 15; 11(3):277-81. PubMed ID: 15617348 [Abstract] [Full Text] [Related]
11. [Anti-virus effect of hepatocyte stimulating substance (HSS) on duck hepatitis B virus in vivo]. Chen G, Chen J, Liu D, Zhang X, Zhu C, Li Y, Wang L, Yang Y, Cai G, Han F. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec 15; 11(4):329-32. PubMed ID: 15617240 [Abstract] [Full Text] [Related]
12. [Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling]. Hu Q, Fang Y, Zhang ZM, Zhang XY, Zhang ZH, Yang DL. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr 15; 22(2):113-5. PubMed ID: 18574531 [Abstract] [Full Text] [Related]
15. Cellular immune response of ducks to duck hepatitis B virus infection. Vickery K, Cossart Y, Dixon R. J Med Virol; 1999 May 15; 58(1):19-25. PubMed ID: 10223541 [Abstract] [Full Text] [Related]
16. The effect of surgical immunomodulation on liver inflammation and clearance of DHBV infection. Vickery K, Tohidi-Esfahani R, Pouliopoulos J, Welschinger R, Dixon R, Deva A, Cossart Y. J Med Virol; 2006 Dec 15; 78(12):1572-8. PubMed ID: 17063509 [Abstract] [Full Text] [Related]
17. Delipidation of a hepadnavirus: Viral inactivation and vaccine development. Cham BE, Vickery K, Tohidi-Esfahani R, Cossart Y. J Virol Methods; 2006 Oct 15; 137(1):160-3. PubMed ID: 16808980 [Abstract] [Full Text] [Related]
18. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection. Le Mire MF, Miller DS, Foster WK, Burrell CJ, Jilbert AR. J Virol; 2005 Oct 15; 79(19):12242-52. PubMed ID: 16160150 [Abstract] [Full Text] [Related]
19. Hepatic neoplasms in aflatoxin B1-treated, congenital duck hepatitis B virus-infected, and virus-free pekin ducks. Cullen JM, Marion PL, Sherman GJ, Hong X, Newbold JE. Cancer Res; 1990 Jul 01; 50(13):4072-80. PubMed ID: 1972346 [Abstract] [Full Text] [Related]
20. [Comparison of specific immune responses to duck hepatitis B virus in infected, immune, and uninfected ducks]. Tang N, Huang A, Guo S, Qi Z, Zhang D. Zhonghua Gan Zang Bing Za Zhi; 2001 Jun 01; 9(3):166-8. PubMed ID: 11412394 [Abstract] [Full Text] [Related] Page: [Next] [New Search]